Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Document Type
Journal Article
Publication Date
12-1-2020
Journal
The Lancet Oncology
Volume
21
Issue
12
Inclusive Pages
e575-e588
DOI
10.1016/S1470-2045(20)30485-X
APA Citation
Bennett, C., Schoen, M., Hoque, S., Witherspoon, B., Aboulafia, D., Hwang, C., Ray, P., Yarnold, P., Chen, B., Schooley, B., Taylor, M., Wyatt, M., Hrushesky, W., & Yang, Y. (2020). Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.. The Lancet Oncology, 21 (12). http://dx.doi.org/10.1016/S1470-2045(20)30485-X
Peer Reviewed
1
